Jilin Aodong Pharmaceutical Group Co Ltd Total Liabilities

Latest as of March 2026: CN¥3.55 Billion CNY ≈ $519.98 Million USD

Jilin Aodong Pharmaceutical Group Co Ltd total liabilities. Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has total liabilities worth CN¥3.55 Billion CNY (≈ $519.98 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Jilin Aodong Pharmaceutical Group Co Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Jilin Aodong Pharmaceutical Group Co Ltd (1993–2025)

Total liabilities of Jilin Aodong Pharmaceutical Group Co Ltd from 1993 to 2025. This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Jilin Aodong Pharmaceutical Group Co Ltd to see how much of total assets are deployed in long-term investments.

Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Fujian Sunner Development Co Ltd SHE:002299	China	CN¥13.21 Billion
Stadler Rail AG SW:SRAIL	Switzerland	CHF5.35 Billion
Agilysys Inc NASDAQ:AGYS	USA	$134.52 Million
Digitalbridge Group Inc NYSE:DBRG	USA	$1.12 Billion
Relay Therapeutics Inc NASDAQ:RLAY	USA	$57.43 Million
First BanCorp F:OLWN	Germany	€17.40 Billion
ERMENEGILDO ZEG.DL -0001 F:JN0	Germany	€1.74 Billion
Bavarian Nordic CO:BAVA	Denmark	Dkr2.08 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) total assets.

Liquidity & Leverage Metrics

Jilin Aodong Pharmaceutical Group Co Ltd Total Liabilities Ratios Explained

Jilin Aodong Pharmaceutical Group Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jilin Aodong Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jilin Aodong Pharmaceutical Group Co Ltd (1993–2025)

The table below shows the annual total liabilities of Jilin Aodong Pharmaceutical Group Co Ltd from 1993 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥3.53 Billion ≈ $516.69 Million	-5.07%
2024-12-31	CN¥3.72 Billion ≈ $544.30 Million	-21.96%
2023-12-31	CN¥4.77 Billion ≈ $697.49 Million	-1.60%
2022-12-31	CN¥4.84 Billion ≈ $708.82 Million	+20.24%
2021-12-31	CN¥4.03 Billion ≈ $589.52 Million	+3.91%
2020-12-31	CN¥3.88 Billion ≈ $567.32 Million	+15.51%
2019-12-31	CN¥3.36 Billion ≈ $491.12 Million	-1.70%
2018-12-31	CN¥3.41 Billion ≈ $499.60 Million	+159.05%
2017-12-31	CN¥1.32 Billion ≈ $192.86 Million	-10.13%
2016-12-31	CN¥1.47 Billion ≈ $214.59 Million	-34.84%
2015-12-31	CN¥2.25 Billion ≈ $329.31 Million	+102.65%
2014-12-31	CN¥1.11 Billion ≈ $162.50 Million	+10.38%
2013-12-31	CN¥1.01 Billion ≈ $147.21 Million	-16.72%
2012-12-31	CN¥1.21 Billion ≈ $176.78 Million	+22.54%
2011-12-31	CN¥985.86 Million ≈ $144.26 Million	+51.11%
2010-12-31	CN¥652.43 Million ≈ $95.47 Million	+8.41%
2009-12-31	CN¥601.83 Million ≈ $88.07 Million	-5.18%
2008-12-31	CN¥634.74 Million ≈ $92.88 Million	-14.79%
2007-12-31	CN¥744.94 Million ≈ $109.01 Million	-21.11%
2006-12-31	CN¥944.28 Million ≈ $138.18 Million	+13.79%
2005-12-31	CN¥829.84 Million ≈ $121.43 Million	-6.77%
2004-12-31	CN¥890.13 Million ≈ $130.25 Million	+48.31%
2003-12-31	CN¥600.19 Million ≈ $87.83 Million	-1.60%
2002-12-31	CN¥609.94 Million ≈ $89.25 Million	+18.99%
2001-12-31	CN¥512.58 Million ≈ $75.01 Million	+57.61%
2000-12-31	CN¥325.23 Million ≈ $47.59 Million	-30.03%
1999-12-31	CN¥464.78 Million ≈ $68.01 Million	+118.80%
1998-12-31	CN¥212.43 Million ≈ $31.08 Million	-5.81%
1997-12-31	CN¥225.52 Million ≈ $33.00 Million	+26.44%
1996-12-31	CN¥178.36 Million ≈ $26.10 Million	+23.63%
1995-12-31	CN¥144.27 Million ≈ $21.11 Million	+6.66%
1994-12-31	CN¥135.27 Million ≈ $19.79 Million	+15.88%
1993-12-31	CN¥116.73 Million ≈ $17.08 Million	--

About Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.95 Billion

CN¥20.14 Billion CNY

Market Cap Rank

#4796 Global

#726 in China

Share Price

CN¥16.84

Change (1 day)

+2.75%

52-Week Range

CN¥16.39 - CN¥21.48

All Time High

CN¥24.39